Akira Takaki

Reversible Restrictive Lung Disease in Pseudomesotheliomatous Carcinoma in a Lung Harboring a HER2-mutation

S. Saeki, S. Sakata, K. Fujii, 2018, Internal medicine.

Successful treatment by pembrolizumab in a patient with end-stage renal disease with advanced non-small cell lung cancer and high PD-L1 expression.

S. Saeki, S. Sakata, Kazuyoshi Nakamura, 2018, Respiratory investigation.

Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer

Y. Tomita, Koei Ikeda, T. Sakagami, 2022, International journal of molecular sciences.

Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.

H. Nakayama, S. Saeki, S. Sakata, 2017, Respiratory investigation.

Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with ALK Rearrangement-Positive Large Cell Neuroendocrine Carcinoma

Y. Tomita, T. Sakagami, N. Hirata, 2020, International journal of molecular sciences.

Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations

Hirotake Tsukamoto, T. Sakagami, T. Ueno, 2023, Cancers.

Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study.

K. Murotani, T. Tokito, T. Sakagami, 2024, Clinical lung cancer.